NCT04506736

Brief Summary

the purpose of this study is to compare open lung approach versus conventional protective ventilation in obese patients undergoing open abdominal surgery

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 24, 2020

Completed
17 days until next milestone

First Posted

Study publicly available on registry

August 10, 2020

Completed
5 days until next milestone

Study Start

First participant enrolled

August 15, 2020

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2022

Completed
Last Updated

May 24, 2022

Status Verified

May 1, 2022

Enrollment Period

1.6 years

First QC Date

July 24, 2020

Last Update Submit

May 23, 2022

Conditions

Keywords

Open lung approachconventional ventilation

Outcome Measures

Primary Outcomes (1)

  • post-operative pulmonary complications

    Pulmonary function tests will be done before surgery as a baseline then repeated after the surgery when the patient is fully awake using bedside spirometer in the sitting position.

    one week postoperative

Secondary Outcomes (8)

  • heart rate

    Baseline (before surgery) and intraoperative

  • airway pressure

    intraoperative

  • pulmonary complications.

    one week postoperative

  • length of hospital stay,

    postoperative up to one month

  • mean arterial blood pressure

    Baseline (before surgery) and intraoperative

  • +3 more secondary outcomes

Study Arms (2)

SPV spontanous ventilation

ACTIVE COMPARATOR

The patients will be ventilated using volume controlled ventilation (7ml/kg tidal volume) with addition of 5 cm H₂O fixed PEEP till the end of the surgery .

Other: spontanous ventilation

OLA open lung ventilation

ACTIVE COMPARATOR

The patients will undergo ARM followed by personalized PEEP.

Other: ARM

Interventions

ARMOTHER

The ARM is performed by setting the peak inspiratory pressure to 45 cmH₂O then changing the mode of ventilation to pressure controlled ventilation (PCV) with the inspiratory pressure set to give a tidal volume equal to that given during VCV, I:E ratio of 1:1 and a PEEP of 5 cmH₂O. The PEEP level is then increased in 5 cmH₂O steps every minute till it reaches 20 cmH₂O and inspiratory pressure is increased to get an airway opening pressure (inspiratory pressure + PEEP) of 40 cmH₂O which is maintained for one minute after which the ventilation returned to the original setting except for the PEEP level which is kept at 20 cmH₂O. The titration of individualized PEEP is done by decremental reduction of the 20 cmH₂O PEEP level in 2 cmH₂O steps every 2 minutes and measuring static compliance of the respiratory system (CRS) at each step.

Also known as: followed by personalized PEEP.
OLA open lung ventilation

volume controlled ventilation (7ml/kg tidal volume) with addition of 5 cm H₂O fixed PEEP till the end of the surgery .

SPV spontanous ventilation

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient aged between 18 - 65 years
  • BMI between 30-40 kg/m²
  • ASA I and II,open elective abdominal surgery which is expected to last for more than 2 hours under general anesthesia and planned to be extubated at the end of surgery

You may not qualify if:

  • Emergency surgery, pregnancy, chronic obstructive pulmonary disease (FEV1 \< 80% of the predicted value)
  • active asthma, acute respiratory distress syndrome
  • history of pneumothorax, lung cyst, Difficult airway, obstructive sleep apnea,ischemic heart disease, heart failure
  • significant arrhythmias and intracranial hypertension. Exposure to radiotherapy and chemotherapy within 2 months before surgery. Advanced Cardiovascular ,liver, renal diseases ischemic heart disease, heart failure, significant arrhythmias and intracranial hypertension

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine,Zagazig University

Zagazig, Zagazig, Elsharkia,egypt, 44519, Egypt

Location

Study Officials

  • Howida A kamal, M.D

    zagazig U

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
Participant, Care Provider
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecture of anesthesia and surgical intensive care (Principal Investigator)

Study Record Dates

First Submitted

July 24, 2020

First Posted

August 10, 2020

Study Start

August 15, 2020

Primary Completion

March 30, 2022

Study Completion

April 30, 2022

Last Updated

May 24, 2022

Record last verified: 2022-05

Locations